狂妄症的提升特异性:狂妄症亚型化倡议
Emily M L Bowman1,2, Nathan E Brummel3, Gideon A Caplan4
1Centre for Public Health, Queen's University Belfast, Block B, Institute of Clinical Sciences, Royal Victoria Hospital Site, Belfast, Northern Ireland.
概括
标准化妄想评估对于理解其多种原因和开发有针对性的治疗至关重要. 狂妄症亚型化倡议 (DSI) 建议详细收集临床和生物数据,以更好地描述狂妄症.
科学领域:
- 老年学是一门学科.
- 神经学 神经学
- 精神病学是一个精神病学.
背景情况:
- 妄想是一种常见的综合征,其原因和表现各异,与不利的长期结果有关.
- 目前分析妄想的方法可能会掩盖潜在的病理生理学,并阻碍有针对性的治疗开发.
- 现有的狂妄症亚型依赖于可观察的特征,可能缺少关键的生物学基础.
研究的目的:
- 建议改进的方法来表征妄的亚型.
- 通过推数据收集和分析的标准化方法,指导未来的妄研究.
- 提高对妄异质性的理解,并确定潜在的生物标志物.
主要方法:
- 在Delirium Subtyping Initiative (DSI) 的三个会议中召开了由25名专家组成的国际小组.
- 收集了关于痴呆症研究建议的专家共识,涵盖临床特征,研究设计和数据分析.
- 专注于开发方法来补充现有的痴呆症诊断标准.
主要成果:
- 专家建议进一步描述妄想特征,超出目前的诊断标准.
- 建议将临床观察与生物样本采集集成,以便在研究中进行标准化,一致的测量.
- 支持分析大型数据集,将临床和生物标记数据结合起来,以确定时间生物学关联.
结论:
- 清晰地定义,标准化和操作化妄特征是必不可少的.
- 对临床和生物标志物数据的综合分析对于推进妄想研究至关重要.
- 未来的妄想查应包括对沟通和推理能力的评估.
关键词:
急性脑病变是一种急性脑病变.生物标志物 生物标志物临床特征 临床特征 临床特征认知变化 认知变化妄想 妄想 妄想 妄想 妄想终极类型 终极类型 终极类型亚现象类型的亚现象类型亚型子类型 亚型子类型更多相关视频
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
32.5K
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
12.2K
相关概念视频
01:30Dementia
139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
139
01:26Psychosis: Goals of Pharmacotherapy
168
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
168
01:26Positive Symptoms Schizophrenia: Hallucinations and Delusions
102
Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
Hallucinations
Hallucinations in...
102
01:30Positive Symptoms of Schizophrenia: Hallucinations and Delusions
176
Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
176
01:27Diagnostic and Statistical Manual of Mental Disorders (DSM)
95
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
95
01:26Alzheimer's Disease: Overview
522
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
522